Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic

Sang-Min Kang1, Seung-Jae Won, Gun-Hee Lee

  • 1National Research Laboratory of Hepatitis C Virus, Ilsong Institute of Life Science, Hallym University, Dongan-gu, Anyang, Republic of Korea.

FEBS Letters
|September 1, 2010
PubMed

Insights

Hepatitis C virus (HCV) NS5A protein from genotypes 1b and 2a similarly inhibits interferon (IFN) responses. This suggests other host factors influence genotypic differences in IFN resistance observed in patients.

Area of Science:

  • Virology
  • Immunology
  • Hepatology

Background:

  • Interferon (IFN) therapy is crucial for treating Hepatitis C virus (HCV) infections.
  • Varied patient responses to IFN treatment are linked to different HCV genotypes.
  • The NS5A protein's role in IFN resistance and genotypic variations requires further investigation.

Purpose of the Study:

  • To investigate the impact of HCV NS5A protein on interferon resistance.
  • To compare genotypic differences in the NS5A protein's effect on IFN resistance.

Main Methods:

  • Assessing the inhibitory effects of genotype 1b and 2a NS5A proteins on IFN-α, poly I:C, and Sendai virus-induced ISRE transcriptional activities.
  • Evaluating the extent of IFN-α-induced antiviral activity mediated by genotype 1b and 2a NS5A proteins.

Main Results:

  • Both genotype 1b and 2a NS5A proteins inhibited IFN-α, poly I:C, and Sendai virus-induced ISRE transcriptional activities.
  • Genotype 1b and 2a NS5A proteins demonstrated similar levels of IFN-α-induced antiviral activity.
  • No significant differential IFN responses were observed between genotype 1b and 2a NS5A proteins.

Conclusions:

  • HCV NS5A protein from both genotype 1b and 2a exhibits similar IFN resistance mechanisms.
  • The observed genotypic differences in IFN response among HCV patients may involve host factors beyond NS5A.
  • Further research is needed to identify host factors contributing to differential IFN antagonism in HCV.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...